Publication
What are employers' obligations during election periods?
On March 23, the Prime Minister of Canada called a federal election to be held on April 28.
Life Sciences Global Guide
Canada | Publication | November 2023
Norton Rose Fulbright lawyers Kristin Wall, Randy Sutton, Veronique Barry, Christopher Guerreiro and Sarah Pennington contributed the Canada chapters to the Practical Law Life Sciences Global Guide on commercialization and regulation. The Guide is published in a Q&A format by Thomson Reuters, which is a leading global platform for trusted, up-to-date legal know how across all major practice areas.
Life Sciences Commercialisation in Canada: Overview
The Q&A Guide to life sciences commercialisation in Canada provides an overview of Canada’s life sciences sector, pricing and state funding, distribution and sale, importing, advertising, patents, trade marks, competition law, and product liability.
Life Sciences Regulation in Canada: Overview
The Q&A guide to life sciences regulation in Canada reviews the main legislation governing pharmaceuticals in Canada. The guide provides an overview of key practical issues, including clinical trials, manufacturing, marketing, abridged procedures, pharmacovigilance, data privacy, packaging and labelling, biological medicines, medical devices, health care IT, combination products, and natural health products.
Recent publications
Publication
Crypto assets are making their way into Regulation 81-102 respecting Investment Funds
On March 27, the Autorité des marchés financiers (AMF, Quebec’s financial markets regulator) published proposed amendments (the Amendments) in a publication titled Regulation to amend Regulation 81-102 respecting Investment Funds pertaining to crypto assets.
Subscribe and stay up to date with the latest legal news, information and events . . .